Cencora, Inc. (ETR:ABG)
Germany · Delayed Price · Currency is EUR 308.95
+0.45 (0.15%)
Inactive · Last trade price on Mar 13, 2026
Cencora Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 325,778 | 321,333 | 293,959 | 262,173 | 238,587 | 213,989 |
Revenue Growth | 7.45% | 9.31% | 12.12% | 9.89% | 11.49% | 12.69% |
Gross Profit Gross Profit Growth | 11,771 | 11,242 | 9,739 | 8,720 | 8,295 | 6,774 |
Operating Income Operating Income Growth | 3,921 | 3,697 | 2,986 | 2,447 | 2,752 | 2,675 |
Net Income Net Income Growth | 1,625 | 1,554 | 1,509 | 1,745 | 1,699 | 1,540 |
Earnings Per Share EPS Growth | 8.33 | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 |
EPS Growth | 18.64% | 5.71% | -11.72% | 6.09% | 8.80% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
US Human Health US Human Health Growth | - | 285,288 | 259,974 | 229,717 | 207,284 | 197,777 |
US Animal Health US Animal Health Growth | - | 5,695 | 5,366 | 5,043 | 4,816 | 4,684 |
International Alliance Healthcare International Alliance Healthcare Growth | 26,042 | 24,395 | 23,062 | 22,349 | 21,890 | 7,373 |
Other Healthcare Solutions Other Healthcare Solutions Growth | 4,773 | 5,971 | 5,566 | 5,069 | 4,601 | 4,156 |
Eliminations Eliminations Growth | -107.86 | -15.53 | -8.37 | -4.49 | -4.87 | -2.33 |
Revenue (Total) Revenue (Total) Growth | 332,771 | 321,333 | 293,959 | 262,173 | 238,587 | 213,989 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 1,753 | 4,356 | 3,133 | 2,592 | 3,388 | 2,547 |
Total Debt Total Debt Growth | 9,905 | 9,331 | 5,623 | 5,894 | 6,725 | 7,805 |
Net Cash (Debt) Net Cash Growth | -8,152 | -4,975 | -2,490 | -3,302 | -3,337 | -5,258 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -41.75 | -25.49 | -12.43 | -16.14 | -15.80 | -25.22 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4,289 | 3,875 | 3,485 | 3,911 | 2,703 | 2,667 |
Capital Expenditures CapEx Growth | -681.46 | -667.98 | -487.17 | -458.36 | -496.32 | -438.22 |
Free Cash Flow Free Cash Flow Growth | 3,607 | 3,207 | 2,998 | 3,453 | 2,207 | 2,228 |
Free Cash Flow Growth | - | 6.99% | -13.19% | 56.47% | -0.97% | 21.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 3.61% | 3.50% | 3.31% | 3.33% | 3.48% | 3.17% |
Operating Margin | 1.20% | 1.15% | 1.02% | 0.93% | 1.15% | 1.25% |
Pretax Margin | 0.72% | 0.70% | 0.68% | 0.82% | 0.91% | 1.04% |
Profit Margin | 0.50% | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% |
FCF Margin | 1.11% | 1.00% | 1.02% | 1.32% | 0.92% | 1.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 24, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.121 | 2.200 | 2.040 | 1.940 | 1.840 | 1.760 |
Dividend Per Share Growth | 1.75% | 7.84% | 5.16% | 5.44% | 4.54% | 6.02% |
Dividend Yield | 0.80% | 0.71% | - | 1.32% | 1.35% | 1.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 24, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 39.66 | 38.99 | 29.23 | 20.71 | 16.51 | 16.12 |
P/FCF Ratio | 17.87 | 18.89 | 14.72 | 10.47 | 12.71 | 11.14 |
PS Ratio | 0.20 | 0.19 | 0.15 | 0.14 | 0.12 | 0.12 |